The retail pharmacy chain will have a total of 71 testing sites in 12 states with capacity to conduct a total of 10,000 tests daily.
All testing sites are using self-swab nasal tests that are overseen by Rite Aid pharmacists.
Most of the sites will operate through store drive thru-windows starting, the company said.
Rite Aid also is expanding its testing criteria to include asymptomatic adults.
Read the full news release here.
More articles on pharmacy:
CVS’ goal of opening 1,500 HealthHubs on track despite pandemic
FDA clarifies relaxed compounding rules for pharmacies
Gilead gets FDA emergency use authorization for remdesivir
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.